

Oscar Health vs Radian
Oscar Health is a tech-forward health insurer burning cash to acquire members and reshape the individual insurance market, while Radian is a mature mortgage insurance specialist that's been generating steady capital returns for years. Both companies are fundamentally insurance businesses whose fortunes hinge on the macroeconomic backdrop, whether that's healthcare costs or the housing credit cycle. Digging into Oscar Health vs Radian shows what growth-stage disruption looks like compared to a seasoned niche insurer playing defense on a shrinking addressable market.
Oscar Health is a tech-forward health insurer burning cash to acquire members and reshape the individual insurance market, while Radian is a mature mortgage insurance specialist that's been generating...
Investment Analysis

Oscar Health
OSCR
Pros
- Oscar Health has expanded its technology platform to support both direct health plans and third-party providers, enhancing its market reach.
- The company operates in the growing individual and small group health insurance segment, benefiting from increased demand for flexible coverage options.
- Oscar Health maintains a relatively low price-to-sales ratio compared to sector peers, suggesting potential undervaluation.
Considerations
- Oscar Health continues to report net losses, reflected in its negative price-to-earnings ratio, raising concerns about profitability.
- The stock faces significant downside risk as analyst targets suggest a potential decline from current levels.
- The company's business model is highly sensitive to regulatory changes and healthcare policy shifts, which could impact margins and growth.

Radian
RDN
Pros
- Radian Group demonstrates strong profitability with consistent year-on-year growth in both revenue and net income.
- The company offers a competitive dividend yield, supported by a stable cash flow from its core mortgage insurance operations.
- Radian's low price-to-earnings ratio suggests the stock may be attractively valued relative to its earnings performance.
Considerations
- Radian's financial results are closely tied to the US housing market, exposing it to cyclical downturns and interest rate volatility.
- Analysts have assigned a 'Hold' rating, indicating limited near-term upside potential despite solid fundamentals.
- Future earnings could normalize as the mortgage insurance market matures and competition intensifies.
Buy OSCR or RDN in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


